Gaudium IVF and Women Health delivery percentage & share price.
· data for the trading session of Wed 18 Nov 2026
Price, volume and delivery
Candles adjusted for splits and bonuses. In the lower panel, the grey bar is the day’s volume and the coloured bar is the part that was delivered; bright green marks big-buyer days (delivered shares 3× the stock’s normal or more, with a normal-or-higher delivery %).
GAUDIUMIVF share price today: what happened on 18 November
Written from NSE’s end-of-day data for 18 Nov 2026. Updated every trading evening. Facts, not advice.
GAUDIUMIVF ended down at ₹97.40 on Wednesday, 18 November 2026, down ₹4.71 or 4.61% from the previous close of ₹102.11. It opened at ₹104.00 and traded between ₹96.67 and ₹104.00, a range of 7.2% of its price, and finished near the bottom of that range. The day began with a 1.9% gap up, which was filled during the session. Among the 126 Pharma & healthcare stocks we track, it ranked 122nd by today’s move; the typical stock in the sector moved -0.53%.
This was its 5th fall in a row. It closed higher on 2 of the last 10 sessions and is -9.2% over that stretch. Over longer periods: one week -11.7%, one month -0.2%, three months -16.0%.
2.67 lakh shares changed hands, worth about ₹2.6 crore, 0.7 times the 20-session average, a quieter day than usual. Of those, 48% (1.29 lakh shares) were taken for delivery, meaning they actually changed owners instead of being traded within the day. That compares with a 60-session average of 39%, so more of today’s trading was by holders than usual. There were 2 big-buyer days (delivery several times above normal) in the last three months.
The close is 9.3% below the 50-day average of ₹107.37. The 14-day RSI, a 0–100 gauge of recent momentum, reads 39, in the neutral zone between 30 and 70. It sits 40.3% below its 52-week high of ₹163.18 and 40.8% above the low of ₹69.18, in the lower part of the year’s range.
Looking at where shares were actually delivered over the past year, the busiest price zone below today’s close is around ₹79.00 (-18.8%), and the busiest zone above it is around ₹105 (+7.3%). Prices often slow down near such zones because many holders bought there, but they are history, not predictions.
On a typical day GAUDIUMIVF moves about ±3.9%, and its average session spans 5.6% from high to low. It closed higher on 42% of the sessions since listing (178 sessions). It opened with a gap of 1% or more 121 times in that time (53 up, 68 down). Its best day since listing was 22 April 2026 (+13.90%) and its worst was 19 March 2026 (-15.01%).
Last five sessions
| Day | Close | Change | Volume | Delivery |
|---|---|---|---|---|
| Wed 18 Nov | ₹97.40 | -4.61% | 2.67 lakh | 48% |
| Tue 17 Nov | ₹102.11 | -1.27% | 1.42 lakh | 52% |
| Mon 16 Nov | ₹103.42 | -2.56% | 4.08 lakh | 40% |
| Fri 13 Nov | ₹106.14 | -1.36% | 3.55 lakh | 38% |
| Thu 12 Nov | ₹107.60 | -2.44% | 3.79 lakh | 44% |
Price levels by delivered volume
Where the most GAUDIUMIVF shares were actually delivered over the last year. Each day’s delivered shares are spread across that day’s high–low range; the peaks are the busiest price zones. Below the close: support zones; above: resistance zones. History, not a forecast.
- Resistance 1₹118+20.8% · 4.9% of the year’s delivery
- Resistance 2₹105+7.3% · 9.0% of the year’s delivery
- Last close₹97.4018 Nov
- Support 1₹79.00-18.8% · 7.5% of the year’s delivery
GAUDIUMIVF IPO
How the GAUDIUMIVF IPO listed and what the share did after. Full IPO page: subscription, listing day and returns after listing →
Its listing gain beat 41% of the 227 main-board IPOs since Oct 2024. How IPOs usually do after listing →
GAUDIUMIVF score
Ranked 0–100 against 1,356 NSE stocks (prices of 18 Nov 2026). Relative ranks for learning, not advice.
Passes 6 of 10 checks on the 18-point checklist.
See how GAUDIUMIVF’s scores are made and the full checklist →GAUDIUMIVF at a glance
- GAUDIUMIVF closed at ₹97.40 on 18 Nov 2026 (-4.61% on the day).
- It trades 40.3% below its 52-week high of ₹163.18 and 40.8% above its low of ₹69.18.
- 48% of the shares traded on 18 Nov were delivered, against a 60-session average of 39%.
- It had 2 big-buyer days (delivery 3× its normal or more) in the last three months.
- A typical day moves it about ±3.9%: more volatile than 98% of the 1,443 most traded NSE stocks.
- Fundamentals: P/E 28.1.
GAUDIUMIVF company details
From the exchanges’ own records: NSE and BSE listings and their industry classification.
- Sector
- Pharma & healthcare
- Industry
- Healthcare Service Provider
- Macro sector
- Healthcare
- ISIN
- INE0P8B01020
- NSE symbol
- GAUDIUMIVF
- BSE code
- 544709
- Listed on NSE since
- 27 February 2026
- Face value
- ₹5 per share
GAUDIUMIVF pros and cons
Written automatically from the latest results, shareholding, valuation against its sector, and price and delivery data. Facts, not advice.
Pros
- P/E of 28.1 is below its sector’s median of 41.6.
Cons
- Large lease commitments: finance costs are far higher than its borrowings explain, and leases are not counted in borrowings.
- Foreign investors (FIIs) cut their stake by 1.8 points last quarter, to 1.2%.
- 40% below its 52-week high.
- More volatile than 98% of the most traded NSE stocks.
GAUDIUMIVF stock DNA
Where GAUDIUMIVF sits among the 1,443 most traded NSE stocks, on a 0–100 scale: 0 is the lowest of all of them, 100 the highest. From the last year of daily data. The first row is the RS rating used on our relative strength ranking.
How GAUDIUMIVF usually moves
Every session of the last year by size of move. The white line is the last session.
Best day 22 Apr 2026 (+13.90%), worst 19 Mar 2026 (-15.01%).
GAUDIUMIVF vs NIFTY 50, one year
Both start at 100. The shaded gap is how far GAUDIUMIVF is ahead of or behind the market.
GAUDIUMIVF fundamentals
Quarterly results and shareholding from NSE filings. Profit is the share owed to the company’s own shareholders. Compare in the stock screener →
Revenue
₹ crore per quarter (consolidated); L = lakh crore, k = thousand crore.
Net profit
₹ crore per quarter (consolidated); L = lakh crore, k = thousand crore.
Who owns GAUDIUMIVF
Shareholding pattern for the quarter to 30 Sep 2026, from the company’s filing with NSE.
Change since Jun 2026:
Promoter holding over time
Promoter and promoter group stake, every quarter.
GAUDIUMIVF balance sheet, returns and cash flow
From the consolidated half-year and annual results filed with NSE (latest: 30 Sep 2026), on the same basis as the quarterly figures above.
| Mar 2026full year | Sep 2026half year | |
|---|---|---|
| Shareholders’ equity | ₹152 Cr | ₹163 Cr |
| Borrowings (excl. leases) | ₹23.1 Cr | ₹4.8 Cr |
| Cash, bank balances & current investments | ₹8.8 Cr | ₹20.5 Cr |
| Operating cash flow | ₹7.2 Cr | ₹19.8 Cr |
| Capex (PPE + intangibles) | ₹2.1 Cr | ₹4.9 Cr |
Balance sheet items are as at the date shown; cash flows cover the half year or full year to that date. ₹ crore.
Gaudium IVF and Women Health vs peers
GAUDIUMIVF is number 119 of 121 Pharma & healthcare companies by market cap. The table shows it with the 7 companies nearest to it in size. P/E is on the last four quarters’ profit, growth compares the latest quarter with a year earlier, Q / V / M are ChartMine scores (quality, valuation, momentum, 0–100) for 17 Nov 2026. Tap a column heading to sort.
| Bajaj Healthcare | 320.25 | 1,078 | 52.8 | 1.9 | 3.9 | 19% | 27% | 8% | −27% | 33 | 59 | 41 |
| Laxmi Dental | 195.39 | 1,076 | 33.2 | 4.1 | 13.1 | 10% | 18% | 13% | −36% | 56 | 47 | 43 |
| Lincoln Pharmaceuticals | 514.45 | 1,030 | 10.6 | 1.3 | 12.7 | 17% | 2% | 11% | −4% | 67 | 94 | 28 |
| Amanta Healthcare | 237.38 | 922 | 46.9 | 4.0 | 9.1 | 17% | 302% | 6% | 98% | 20 | 39 | 97 |
| Zim Laboratories | 135.47 | 727 | 255.6 | 2.5 | 0.8 | 19% | – | −2% | 82% | 15 | 43 | 79 |
| GAUDIUMIVF | 97.40 | 709 | 28.1 | 4.3 | 14.2 | – | – | 25% | – | 61 | 54 | – |
| Wanbury | 174.38 | 610 | – | 3.9 | – | – | – | 5% | −25% | – | – | – |
| AAREYDRUGS | 107.75 | 344 | 70.0 | 2.0 | 3.3 | 5% | 34% | 2% | 13% | 20 | 47 | 82 |
| Sector median | – | 9,495 | 42.0 | 4.5 | 13.3 | 21% | 26% | 12% | 12% | 54 | 47 | 64 |
Sector: Pharma & healthcare (126 companies). Medians are over every Pharma & healthcare company with that figure. ₹ crore; market cap at the last close.
Delivery and big-buyer days
Delivered shares change owners for real; intraday trades don’t. Days when delivery jumps far above normal often mean large investors were buying or selling.
Delivery calendar, last 12 months
Each square is a session. The brighter the green, the more shares were delivered compared with GAUDIUMIVF’s normal. Hover or tap a square for the day.
Latest big-buyer days
What the price did on the day and five sessions later. Past moves only.
| Date | Delivered | vs normal | Delivery % | Day | 5 days later |
|---|---|---|---|---|---|
| 11 Nov 2026 | 5.14 L | 6.7× | 68% | +3.62% | -11.69% |
| 22 Oct 2026 | 76,471 | 5.3× | 56% | -1.18% | +18.37% |
GAUDIUMIVF timeline
Everything that happened to GAUDIUMIVF, newest first: deals, promoter filings, results, big-buyer days, new highs and big moves.
- November 2026
- 11 NovBig-buyer day: 5.14 L shares delivered, 6.7× normal68% of the day’s volume was delivered; the price closed +3.62%.
- 11 NovBulk deal: Kishan Gopal Mohta sold 4.23 L sharesAt ₹109.02, worth ₹4.6 Cr.
- October 2026
- 29 OctJumped 12.7% in one sessionClosed at ₹111.07, about 3.3× a normal day’s move.
- 22 OctBig-buyer day: 76,471 shares delivered, 5.3× normal56% of the day’s volume was delivered; the price closed -1.18%.
- April 2026
- 22 AprJumped 13.9% in one sessionClosed at ₹117.59, about 3.5× a normal day’s move.
- 9 AprJumped 12.6% in one sessionClosed at ₹89.17, about 3.2× a normal day’s move.
- March 2026
- 19 MarFell 15.0% in one sessionClosed at ₹80.55, about 3.8× a normal day’s move.
My notes on GAUDIUMIVF
Private: saved only in this browser, never sent to us.
Questions
What is the 52-week high and low of GAUDIUMIVF?
What is the delivery percentage of GAUDIUMIVF?
How volatile is GAUDIUMIVF?
What is the market cap of GAUDIUMIVF?
What is the P/E ratio of GAUDIUMIVF?
Who owns GAUDIUMIVF? What is its shareholding pattern?
What is the ROE of GAUDIUMIVF?
What is the book value of GAUDIUMIVF?
Who are GAUDIUMIVF’s peers?
What are the support and resistance levels of GAUDIUMIVF?
What was the IPO price of GAUDIUMIVF?
What is the ISIN of GAUDIUMIVF?
Data from NSE’s daily files, adjusted for splits and bonuses. Past behaviour is not a forecast. This is information, not investment advice; ChartMine is not a SEBI-registered adviser.
